CD40 is essential in the upregulation of traf proteins and NF-KappaB-dependent proinflammatory gene expression after arterial injury

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Song, Zifang ^a   Jin, Rong ^a   Yu, Shiyong ^a   Rivet, Joshua J ^a   Smyth, Susan S ^b   Nanda, Anil ^a   Granger, D Neil ^a   Li, Guohong ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; VASCULAR CELL ADHESION MOLECULE 1; AUTACOID; CD40 LIGAND; THIOGLYCOLIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN FUNCTION; ARTERY INJURY; ARTERY OCCLUSION; ARTICLE; CAROTID ARTERY LIGATION; CONTROLLED STUDY; DISEASE MODEL; DOWN REGULATION; FEMORAL ARTERY; GENE ACTIVATION; GENE EXPRESSION REGULATION; IN VITRO STUDY; LEUKOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MALE; MOUSE; NEOINTIMA; NONHUMAN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; WILD TYPE; ANIMAL; ARTERY; CAROTID ARTERY INJURY; GENETICS; INFLAMMATION; INJURY; LIGATION; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PERITONEUM;

MUS;

ANIMALS; ANTIGENS, CD40; ARTERIES; CAROTID ARTERY INJURIES; CD40 LIGAND; DISEASE MODELS, ANIMAL; FEMORAL ARTERY; GENE EXPRESSION REGULATION; INFLAMMATION; INFLAMMATION MEDIATORS; LIGATION; MICE; NEOINTIMA; NEUTROPHIL INFILTRATION; NF-KAPPA B; PERITONEUM; THIOGLYCOLATES; TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PEPTIDES AND PROTEINS; UP-REGULATION;

EID: 80051840810     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023239     Document Type: Article

References (49)

1. Lutgens E, Lievens D, Beckers L, Donners M, Daemen M, (2007) CD40 and its ligand in atherosclerosis. Trends Cardiovasc Med 17: 118-123.
2. Ferro D, Loffredo L, Polimeni L, Fimognari F, Villari P, et al. (2007) Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation. Arterioscler Thromb Vasc Biol 27: 2763-2768.
3. Engel D, Seijkens T, Poggi M, Sanati M, Thevissen L, et al. (2009) The immunobiology of CD154-CD40-TRAF interactions in atherosclerosis. Semin Immunol 21: 308-312.
4. Bishop GA, Moore CR, Xie P, Stunz LL, Kraus ZJ, (2007) TRAF proteins in CD40 signaling. Adv Exp Med Biol 597: 131-151.
5. Zapata JM, (2003) TNF-receptor-associated factors as targets for drug development. Expert Opin Ther Targets 7: 411-425.
6. Bradley JR, Pober JS, (2001) Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20: 6482-6491.
7. Chung JY, Park YC, Ye H, Wu H, (2002) All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 115: 679-688.
8. Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E, (2009) The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 102: 206-214.
9. Mukundan L, Bishop GA, Head KZ, Zhang L, Wahl LM, et al. (2005) TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages. J Immunol 174: 1081-1090.
10. Xia M, Ling W, Zhu H, Wang Q, Ma J, et al. (2007) Anthocyanin prevents CD40-activated proinflammatory signaling in endothelial cells by regulating cholesterol distribution. Arterioscler Thromb Vasc Biol 27: 519-524.
11. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P, (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature 394: 200-203.
12. Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, et al. (1999) Requirement for CD154 in the progression of atherosclerosis. Nat Med 5: 1313-1316.
13. Miyahara T, Koyama H, Miyata T, Shigematsu H, Inoue J, et al. (2006) Inflammatory responses involving tumor necrosis factor receptor-associated factor 6 contribute to in-stent lesion formation in a stent implantation model of rabbit carotid artery. J Vasc Surg 43: 592-600.
14. Donners MM, Beckers L, Lievens D, Munnix I, Heemskerk J, et al. (2008) The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodeling. Blood 111: 4596-4604.
15. Remskar M, Li H, Chyu KY, Shah PK, Cercek B, (2001) Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury. Circ Res 88: 390-394.
16. Choi ET, Khan MF, Leidenfrost JE, Collins ET, Boc KP, et al. (2004) Beta3-integrin mediates smooth muscle cell accumulation in neointima after carotid ligation in mice. Circulation 109: 1564-1569.
17. Tanaka K, Sata M, Hirata Y, Nagai R, (2003) Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res 93: 783-790.
18. Kumar A, Lindner V, (1997) Remodeling with neointima formation in the mouse carotid artery after cessation of blood flow. Arterioscler Thromb Vasc Biol 17: 2238-2244.
19. Li G, Keenan AC, Young JC, Hall MJ, Pamuklar Z, et al. (2007) Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirdin on myeloperoxidase release from neutrophils. Arterioscler Thromb Vasc Biol 27: 1850-1856.
20. Li G, Sanders JM, Bevard MH, Sun Z, Chumley JW, et al. (2008) CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury. Am J Pathol 172: 1141-1152.
21. Mistry P, Deacon K, Mistry S, Blank J, Patel R, (2004) NF-kappaB promotes survival during mitotic cell cycle arrest. J Biol Chem 279: 1482-1490.
22. Takada Y, Aggarwal BB, (2004) Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9. J Biol Chem 279: 4750-4759.
23. Zirlik A, Bavendiek U, Libby P, MacFarlane L, Gerdes N, et al. (2007) TRAF-1,-2,-3,-5, and-6 are induced in atherosclerotic plaques and differentially mediate proinflammatory functions of CD40L in endothelial cells. Arterioscler Thromb Vasc Biol 27: 1101-1107.
24. Davis C, Fischer J, Ley K, Sarembock IJ, (2003) The role of inflammation in vascular injury and repair. J Thromb Haemost 1: 1699-1709.
25. Sprague AH, Khalil RA, (2009) Inflammatory cytokines in vascular dysfunction and vascular disease. Biochem Pharmacol 78: 539-552.
26. Li Q, Verma IM, (2002) NF-kappaB regulation in the immune system. Nat Rev Immunol 2: 725-734.
27. Ghosh S, Hayden MS, (2008) New regulators of NF-κB in inflammation. Nat Rev Immunol 8: 837-848.
28. Cercek B, Yamashita M, Dimayuga P, Zhu J, Fishbein MC, et al. (1997) Nuclear factor-kappaB activity and arterial response to balloon injury. Atherosclerosis 131: 59-66.
29. Ialenti A, Ianaro A, Maffia P, Carnuccio R, D'Acquisto F, et al. (2001) Role of nuclear factor-kappaB in a rat model of vascular injury. Naunyn Schmiedebergs Arch Pharmacol 364: 343-350.
30. Su CH, Hsieh BT, Leung SW, Wu CJ, Chiu SY, et al. (2007) Increased expression of nuclear NF-kappaB after coronary artery balloon injury can be inhibited by intracoronary beta-irradiation. Int J Radiat Biol 83: 707-716.
31. Koga J, Matoba T, Egashira K, Kubo M, Miyagawa M, et al. (2009) Soluble Flt-1 gene transfer ameliorates neointima formation after wire injury in flt-1 tyrosine kinase-deficient mice. Arterioscler Thromb Vasc Biol 29: 458-464.
32. Evans DJ, Jackman LE, Chamberlain J, Crosdale DJ, Judge HM, et al. (2009) Platelet P2Y(12) receptor influences the vessel wall response to arterial injury and thrombosis. Circulation 119: 116-122.
33. Häkkinen T, Karkola K, Ylä-Herttuala S, (2000) Macrophages, smooth muscle cells, endothelial cells, and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions. Colocalization with epitopes of oxidized low-density lipoprotein, scavenger receptor, and CD16 (Fc gammaRIII). Virchows Arch 437: 396-405.
34. Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, et al. (2007) CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115: 1571-1580.
35. Lutgens E, Lievens D, Beckers L, Wijnands E, Soehnlein O, et al. (2010) Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 207: 391-404.
36. Stachon P, Missiou A, Walter C, Varo N, Colberg C, et al. (2010) Tumor necrosis factor receptor associated factor 6 is not required for atherogenesis in mice and does not associate with atherosclerosis in humans. PLoS One 5: e11589.
37. Missiou A, Köstlin N, Varo N, Rudolf P, Aichele P, et al. (2010) Tumor necrosis factor receptor-associated factor 1 (TRAF1) deficiency attenuates atherosclerosis in mice by impairing monocyte recruitment to the vessel wall. Circulation 121: 2033-2044.
38. Missiou A, Rudolf P, Stachon P, Wolf D, Varo N, et al. (2010) TRAF5 deficiency accelerates atherogenesis in mice by increasing inflammatory cell recruitment and foam cell formation. Circ Res 107: 757-766.
39. He JQ, Saha SK, Kang JR, Zarnegar B, Cheng G, (2007) Specificity of TRAF3 in its negative regulation of the noncanonical NF-kappa B pathway. J Biol Chem 282: 3688-3694.
40. Landry DB, Couper LL, Bryant SR, Lindner V, (1997) Activation of the NF-kappa B and I kappa B system in smooth muscle cells after rat arterial injury. Induction of vascular cell adhesion molecule-1 and monocyte chemoattractant protein-1. Am J Pathol 151: 1085-1095.
41. Breuss JM, Cejna M, Bergmeister H, Kadl A, Baumgartl G, et al. (2002) Activation of nuclear factor-kappa B significantly contributes to lumen loss in a rabbit iliac artery balloon angioplasty model. Circulation 105: 633-638.
42. Bu DX, Erl W, de Martin R, Hansson GK, Yan ZQ, (2005) IKKbeta-dependent NF-kappaB pathway controls vascular inflammation and intimal hyperplasia. FASEB J 19: 1293-1295.
43. Yamasaki K, Asai T, Shimizu M, Aoki M, Hashiya N, et al. (2003) Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model. Gene Ther 10: 356-364.
44. Galkina E, Ley K, (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27: 165-197.
45. Ley K, Laudanna C, Cybulsky MI, Nourshargh S, (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7: 678-689.
46. Qu Y, Shi X, Zhang H, Sun W, Han S, et al. (2009) VCAM-1 siRNA reduces neointimal formation after surgical mechanical injury of the rat carotid artery. J Vasc Surg 50: 1452-1458.
47. Egashira K, Zhao Q, Kataoka C, Ohtani K, Usui M, et al. (2002) Importance of monocyte chemoattractant protein-1 pathway in neointimal hyperplasia after periarterial injury in mice and monkeys. Circ Res 90: 1167-1172.
48. Iwata H, Manabe I, Fujiu K, Yamamoto T, Takeda N, et al. (2010) Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages. Circulation 122: 2048-2057.
49. Becker T, Hartl FU, Wieland F, (2002) CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes. J Cell Biol 158: 1277-1285.